Apple's Balance Sheet Illusion

Mish Shedlock |

The latest 10-Q quarterly filing for Apple, Inc. (AAPL)  shows that it has nearly $203 billion in cash or cash-equivalents.

10-Q Page 31


Current Assets

Diving into a more colorful Nasdaq Summation, I made the following clips (highlights in yellow are mine). 


Totaling actual cash, short-term investments, and over $168 billion in long-term investments, we arrive at the $202.848 billion number on the 10-Q.

Current Liabilities

Apple Graph III - 10-9_1.jpg

Cash Much Smaller Than You Think

I don't often dive into balance sheets, but I did so after reading a MarketWatch opinion by Brett Arends.

Arends writes that Apple’s real cash pile is 99% smaller than you think. Actually, I can quibble with that number a bit, but right off the top of the head, one can easily subtract liabilities to get a better picture of what Apple really has.

Subtract all the liabilities and you are at $55.374 billion.

That's a very good number, but a far cry from media hype. For example CNN Money points out Apple has $203 billion in cash. The title is "technically" accurate, but CNN Money ignores the debt while making the claim that "It's fair to wonder why Apple needs all this cash. It's one thing to save for a rainy day. But Apple seems to be acting like Noah and preparing for a 40-day flood. Apple may face even more pressure to do something productive with its $200 billion war chest instead of letting it collect dust in Ireland and other tax havens." 

Tax Haven Math 

Returning to the 10-Q, we see this note: "As of June 27, 2015 and September 27, 2014, the Company’s cash, cash equivalents and marketable securities held by foreign subsidiaries were $181.1 billion and $137.1 billion, respectively, and are generally based in US dollar-denominated holdings. Amounts held by foreign subsidiaries are generally subject to US income taxation on repatriation to the US."

Arends points out the tax liability on that $181.1 billion held offshore is $59.2 billion. Maybe there is another tax repatriation holiday, but maybe not. And if not, there is another $59.2 billion liability to deal with. In short, Apple could not spend its alleged cash-on-hand without going deeper in debt.

Some of the numbers I took from Nasdaq do not precisely match Arends'. For example, he notes $31.5 billion in “off-balance-sheet” liabilities. That's a number suspiciously close to $31.296 billion in "other liabilities" as noted in my clips. If  “off-balance-sheet” is not included in my totals, then subtract another $31.5 billion.

Distortions of Reality

The key point is that all of these glowing "cash-on-hand" reports that you read are distortions of reality. The primary distortion is that reported cash positions ignore debt. I have gone through this exercise before, and after subtracting liabilities, US corporations actually have negative net cash in aggregate. The secondary distortion, as Arends points out, but I had not done so previously, is that reported cash positions fail to take in tax liabilities. The last time I conducted my analysis was in 2013, so perhaps it's time for an update. A small handful of companies actually have positive net cash. Apple was one of them back then, and it's one of them now. 

Yes, companies in general could spend their reported cash numbers, but to do so would further leverage their balance sheets with debt.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
AAPL Apple Inc. 116.60 -0.46 -0.39 23,192,665


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…